Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-000788
Filing Date
2025-03-12
Accepted
2025-03-12 07:01:30
Documents
2
Period of Report
2025-03-12

Document Format Files

Seq Description Document Type Size
1 6-K zk2532856.htm 6-K 43997
2 image00001.jpg GRAPHIC 315708
  Complete submission text file 0001178913-25-000788.txt   479839
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 25729964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)